STREAMEX CORP

Insider buying at Streamex Corp. shows confidence amid a steep drop, hinting at future tech‑health breakthroughs and potential upside.

Insider buying surge at Streamex Corp. signals confidence in its tokenised liquidity and cardiac tech, but investors face high‑beta risk and revenue volatility.

Streamex Corp’s insider buying and GLDY token launch signal confidence and a tokenized future in cardiac tech – watch the Solana‑based gold‑backed token and regulatory moves.

Insider buying continues at Streamex Corp. – Marciano’s latest 17,745‑share purchase at $1.13 signals confidence amid a volatile stock, with GLDY’s potential earnings and institutional growth fueling investor intrigue.

Streamex’s insider buy signals confidence in its cutting‑edge catheter ablation tech and rising reimbursement upside, offering a high‑growth, risk‑tolerant play for investors.

Insider buying spurs optimism for Streamex Corp., with CFO awarding 500k RSUs at $1.14/unit—signals confidence in a rebound after tax relief and a robust tech pipeline.

Insider buying fuels optimism for Streamex Corp’s tokenized supply platform—clinical safety, 15% efficiency gains, and pending FDA clearance could spark a rally.

Insider buy by GIUSTRA FRANK at $3.00 shows confidence in Streamex Corp., a growing digital‑media player with a $35 M raise, strong 2025 results and AI‑powered growth, but with high risk and volatile market dynamics.

Insider buying at Streamex Corp. shows confidence after a $35M public offer—yet the company’s negative earnings, high volatility, and FDA hurdles remain key risk factors.

Insider Lekstrom Morgan Lee buys 23k Streamex shares at $3.30 after its $35M IPO, signaling confidence in the company’s high‑growth cardiac tech pipeline.